Fairman Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.01K Hold
6
﹤0.01% 254
2026
Q1
$2.95K Hold
6
﹤0.01% 249
2025
Q4
$3.48K Sell
6
-6
-50% -$3.39K ﹤0.01% 241
2025
Q3
$5.83K Hold
12
﹤0.01% 193
2025
Q2
$4.87K Hold
12
﹤0.01% 185
2025
Q1
$6.25K Hold
12
0.01% 167
2024
Q4
$6.25K Hold
12
0.01% 177
2024
Q3
$7.43K Hold
12
0.01% 184
2024
Q2
$6.64K Hold
12
0.01% 188
2024
Q1
$6.98K Hold
12
0.01% 176
2023
Q4
$6.37K Buy
+12
New +$5.81K 0.01% 180

Other funds holding TMO

Fairman Group's TMO Position: Q2 2026 in Review

Fairman Group held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 6 shares worth $3.01K. The position accounts for ﹤0.01% of the portfolio, ranked #254.

Fairman Group first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.43K in Q3 2024. 1,582 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Fairman Group held 6 shares of Thermo Fisher Scientific worth $3.01K as of Q2 2026.
  • Fairman Group left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Fairman Group's portfolio in Q2 2026, its #254 holding.
  • Fairman Group first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Fairman Group's Thermo Fisher Scientific position peaked at $7.43K in Q3 2024.
  • 1,582 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.